0 CHECKOUT

Herpes Simplex Infections - Pipeline Review, H2 2015

  • ID: 3448676
  • September 2015
  • 185 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • 3-V Biosciences, Inc.
  • Beech Tree Labs, Inc.
  • GenVec, Inc.
  • Mymetics Corporation
  • Oryzon Genomics S.A.
  • Sanofi
  • MORE

Herpes Simplex Infections - Pipeline Review, H2 2015

Summary

The report ‘Herpes Simplex Infections - Pipeline Review, H2 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Simplex Infections and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3-V Biosciences, Inc.
  • Beech Tree Labs, Inc.
  • GenVec, Inc.
  • Mymetics Corporation
  • Oryzon Genomics S.A.
  • Sanofi
  • MORE

List of Tables

List of Figures

Introduction

REPORT COVERAGE

Herpes Simplex Infections Overview

Therapeutics Development

Pipeline Products for Herpes Simplex Infections - Overview

Pipeline Products for Herpes Simplex Infections - Comparative Analysis

Herpes Simplex Infections - Therapeutics under Development by Companies

Herpes Simplex Infections - Therapeutics under Investigation by Universities/Institutes

Herpes Simplex Infections - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Herpes Simplex Infections - Products under Development by Companies

Herpes Simplex Infections - Products under Investigation by Universities/Institutes

Herpes Simplex Infections - Companies Involved in Therapeutics Development

3-V Biosciences, Inc.

Adamis Pharmaceuticals Corporation

Admedus Ltd

AiCuris GmbH & Co. KG

Astellas Pharma Inc.

Beech Tree Labs, Inc.

CEL-SCI Corporation

Chimerix, Inc.

Epiphany Biosciences, Inc.

Foamix Pharmaceuticals Ltd.

Genocea Biosciences, Inc.

GenVec, Inc.

Immune Design Corp.

Immunovaccine, Inc.

JN-International Medical Corporation

Microbiotix, Inc.

Mymetics Corporation

NanoBio Corporation

NanoViricides, Inc.

Onxeo SA

Oryzon Genomics S.A.

Osel Inc.

PaxVax

Peregrine Pharmaceuticals, Inc.

Profectus BioSciences, Inc.

Romark Laboratories, L.C.

Sanofi

Sanofi Pasteur SA

Shulov Innovative Science Ltd.

Spider Biotech

Starpharma Holdings Limited

Vaccibody AS

Vaxart, Inc.

Vical Incorporated

Vironova AB

ViroStatics, srl

Herpes Simplex Infections - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Combination Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

(celecoxib + famciclovir) - Drug Profile

acyclovir - Drug Profile

acyclovir - Drug Profile

amenamevir - Drug Profile

Aspidasept - Drug Profile

astodrimer - Drug Profile

Biologic for Infectious Disease - Drug Profile

brincidofovir - Drug Profile

BTL-TMLHSV - Drug Profile

C-31G - Drug Profile

CEL-1000 - Drug Profile

G-103 - Drug Profile

GEN-002 - Drug Profile

GEN-003 - Drug Profile

genital herpes vaccine [HSV-2] - Drug Profile

GV-2207 - Drug Profile

Herpecide - Drug Profile

herpes simplex virus [serotype 2] vaccine - Drug Profile

herpes simplex virus [type 1, 2] vaccine - Drug Profile

herpes simplex virus [type 1] vaccine - Drug Profile

herpes simplex virus [type 2] vaccine - Drug Profile

herpes simplex virus [type 2] vaccine - Drug Profile

herpes simplex virus [type 2] vaccine - Drug Profile

herpes simplex virus [type 2] vaccine - Drug Profile

herpes simplex virus [type 2] vaccine - Drug Profile

herpes simplex virus [type 2] vaccine - Drug Profile

herpes simplex virus [type 2] vaccine - Drug Profile

herpes simplex virus [type 2] vaccine - Drug Profile

herpes simplex virus [type 2] vaccine - Drug Profile

HSV vaccine - Drug Profile

HSV-529 - Drug Profile

MB-66 - Drug Profile

MBX-2168 - Drug Profile

Monoclonal Antibodies for HIV and Herpes Simplex Infections - Drug Profile

Monoclonal Antibody for Herpes Simplex Infections - Drug Profile

Monoclonal Antibody for Herpes Simplex Infections - Drug Profile

Peptide for HIV and HSV Infections - Drug Profile

PGN-632 - Drug Profile

pritelivir - Drug Profile

RC-100b - Drug Profile

RKP-00156 - Drug Profile

SB-105 - Drug Profile

SB-105A10 - Drug Profile

Small Molecule to Inhibit CDK4, CDK6 and CDK9 for EBV and HSV Infections - Drug Profile

Small Molecule to Inhibit LSD-1 for HSV - Drug Profile

Small Molecules for Respiratory Syncitial Virus and Herpes Simplex Virus Infections - Drug Profile

Small Molecules for Viral Infections - Drug Profile

Small Molecules to Inhibit Fatty Acid Synthase for Viral Infections - Drug Profile

Synthetic Peptides for Influenza, HSV and HIV Infections - Drug Profile

Synthetic Peptides for Oncology and Infectious Disease - Drug Profile

Synthetic Peptides for Viral Infections - Drug Profile

Teg-379 - Drug Profile

UB-621 - Drug Profile

valomaciclovir stearate - Drug Profile

VCLHB-01 - Drug Profile

VCLHM-01 - Drug Profile

VN-180 - Drug Profile

ZEP-3 - Drug Profile

Herpes Simplex Infections - Recent Pipeline Updates

Herpes Simplex Infections - Dormant Projects

Herpes Simplex Infections - Discontinued Products

Herpes Simplex Infections - Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Herpes Simplex Infections, H2 2015

Number of Products under Development for Herpes Simplex Infections - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Late Stage Development, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Development, H2 2015

Products under Development by Companies, H2 2015

Products under Development by Companies, H2 2015 (Contd..1)

Products under Development by Companies, H2 2015 (Contd..2)

Products under Development by Companies, H2 2015 (Contd..3)

Products under Investigation by Universities/Institutes, H2 2015

Herpes Simplex Infections - Pipeline by 3-V Biosciences, Inc., H2 2015

Herpes Simplex Infections - Pipeline by Adamis Pharmaceuticals Corporation, H2 2015

Herpes Simplex Infections - Pipeline by Admedus Ltd, H2 2015

Herpes Simplex Infections - Pipeline by AiCuris GmbH & Co. KG, H2 2015

Herpes Simplex Infections - Pipeline by Astellas Pharma Inc., H2 2015

Herpes Simplex Infections - Pipeline by Beech Tree Labs, Inc., H2 2015

Herpes Simplex Infections - Pipeline by CEL-SCI Corporation, H2 2015

Herpes Simplex Infections - Pipeline by Chimerix, Inc., H2 2015

Herpes Simplex Infections - Pipeline by Epiphany Biosciences, Inc., H2 2015

Herpes Simplex Infections - Pipeline by Foamix Pharmaceuticals Ltd., H2 2015

Herpes Simplex Infections - Pipeline by Genocea Biosciences, Inc., H2 2015

Herpes Simplex Infections - Pipeline by GenVec, Inc., H2 2015

Herpes Simplex Infections - Pipeline by Immune Design Corp., H2 2015

Herpes Simplex Infections - Pipeline by Immunovaccine, Inc., H2 2015

Herpes Simplex Infections - Pipeline by JN-International Medical Corporation, H2 2015

Herpes Simplex Infections - Pipeline by Microbiotix, Inc., H2 2015

Herpes Simplex Infections - Pipeline by Mymetics Corporation, H2 2015

Herpes Simplex Infections - Pipeline by NanoBio Corporation, H2 2015

Herpes Simplex Infections - Pipeline by NanoViricides, Inc., H2 2015

Herpes Simplex Infections - Pipeline by Onxeo SA, H2 2015

Herpes Simplex Infections - Pipeline by Oryzon Genomics S.A., H2 2015

Herpes Simplex Infections - Pipeline by Osel Inc., H2 2015

Herpes Simplex Infections - Pipeline by PaxVax, H2 2015

Herpes Simplex Infections - Pipeline by Peregrine Pharmaceuticals, Inc., H2 2015

Herpes Simplex Infections - Pipeline by Profectus BioSciences, Inc., H2 2015

Herpes Simplex Infections - Pipeline by Romark Laboratories, L.C., H2 2015

Herpes Simplex Infections - Pipeline by Sanofi, H2 2015

Herpes Simplex Infections - Pipeline by Sanofi Pasteur SA, H2 2015

Herpes Simplex Infections - Pipeline by Shulov Innovative Science Ltd., H2 2015

Herpes Simplex Infections - Pipeline by Spider Biotech, H2 2015

Herpes Simplex Infections - Pipeline by Starpharma Holdings Limited, H2 2015

Herpes Simplex Infections - Pipeline by Vaccibody AS, H2 2015

Herpes Simplex Infections - Pipeline by Vaxart, Inc., H2 2015

Herpes Simplex Infections - Pipeline by Vical Incorporated, H2 2015

Herpes Simplex Infections - Pipeline by Vironova AB, H2 2015

Herpes Simplex Infections - Pipeline by ViroStatics, srl, H2 2015

Assessment by Monotherapy Products, H2 2015

Assessment by Combination Products, H2 2015

Number of Products by Stage and Target, H2 2015

Number of Products by Stage and Mechanism of Action, H2 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Herpes Simplex Infections Therapeutics - Recent Pipeline Updates, H2 2015

Herpes Simplex Infections - Dormant Projects, H2 2015

Herpes Simplex Infections - Dormant Projects (Contd..1), H2 2015

Herpes Simplex Infections - Dormant Projects (Contd..2), H2 2015

Herpes Simplex Infections - Dormant Projects (Contd..3), H2 2015

Herpes Simplex Infections - Dormant Projects (Contd..4), H2 2015

Herpes Simplex Infections - Discontinued Products, H2 2015

List of Figures

Number of Products under Development for Herpes Simplex Infections, H2 2015

Number of Products under Development for Herpes Simplex Infections - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Late Stage Development, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Products, H2 2015

Assessment by Monotherapy Products, H2 2015

Number of Products by Top 10 Targets, H2 2015

Number of Products by Stage and Top 10 Targets, H2 2015

Number of Products by Top 10 Mechanism of Actions, H2 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015

Number of Products by Top 10 Routes of Administration, H2 2015

Number of Products by Stage and Top 10 Routes of Administration, H2 2015

Number of Products by Top 10 Molecule Types, H2 2015

Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

3-V Biosciences, Inc.
Adamis Pharmaceuticals Corporation
Admedus Ltd
AiCuris GmbH & Co. KG
Astellas Pharma Inc.
Beech Tree Labs, Inc.
CEL-SCI Corporation
Chimerix, Inc.
Epiphany Biosciences, Inc.
Foamix Pharmaceuticals Ltd.
Genocea Biosciences, Inc.
GenVec, Inc.
Immune Design Corp.
Immunovaccine, Inc.
JN-International Medical Corporation
Microbiotix, Inc.
Mymetics Corporation
NanoBio Corporation
NanoViricides, Inc.
Onxeo SA
Oryzon Genomics S.A.
Osel Inc.
PaxVax
Peregrine Pharmaceuticals, Inc.
Profectus BioSciences, Inc.
Romark Laboratories, L.C.
Sanofi
Sanofi Pasteur SA
Shulov Innovative Science Ltd.
Spider Biotech
Starpharma Holdings Limited
Vaccibody AS
Vaxart, Inc.
Vical Incorporated
Vironova AB
ViroStatics, srl

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S